News (1)
4 SARS-CoV-2 vaccines in PRC have entered Phase III trials and are progressing smoothly
Reporter : Zhao Shi / Publisher : The Paper / Ref : http://news.sciencenet.cn/htmlnews/2020/9/446173.shtm / Translation, editing : Gan Yung Chyan, KUCINTA SETIA
At 3 pm on 25 September, the State Council Information Office held a briefing to introduce the progress of the work on the SARS-CoV-2 vaccine. Wu Yuanbin, director of the Department of Social Development and Science of the Ministry of Science and Technology, revealed at the meeting that PRC currently has four covi vaccines that have entered Phase III clinical trials.
Wu Yuanbin said that currently, 11 covi vaccines in PRC have entered clinical trials. Four vaccines have entered phase III clinical trials, of which three are inactivated vaccines and one is adenovirus vector vaccine. Recombinant protein vaccines, nucleic acid vaccines, and attenuated influenza virus vector vaccines are stepping up to carry out Phase I and Phase II clinical trials.
He revealed that the four covi vaccines that have entered phase III clinical trials are currently progressing smoothly.
__________________________________________________________________________________________________
News (2)
Four US vaccines enter the final stage, the US economy shows a strong recovery
Reporter : Jinshi / Publisher : NTD / Ref : https://www.ntdtv.com/gb/2020/09/24/a102948558.html / Translation, editing : Gan Yung Chyan, KUCINTA SETIA
On Wednesday, President Trump announced that the SARS-CoV-2 vaccine produced by four US pharmaceutical companies has entered the final clinical trial stage. At the same time, many areas of the US economy are showing a strong V-shaped recovery trend.
Trump said at a press conference on Wednesday evening that the covi vaccine produced by Johnson & Johnson in the United States has entered clinical trials, becoming the fourth US vaccine to enter clinical trials.
US President Trump said, "We already have 4 vaccine candidates at a very late stage. "Late" is a good word here. We encourage Americans to take part in vaccine testing."
Earlier, US media reported that the US Food and Drug Administration (FDA) plans to introduce more stringent vaccine approval standards, which may delay the vaccine's launch. Trump responded at the press conference that the White House has the final decision to approve the vaccine.
U.S. President Trump said, "It sounds like politically motivated. Because when you have great companies like Pfizer, Johnson & Johnson, and Moderna that develop vaccines, they have already conducted a series of related trials. I want to ask them ( FDA) why add longer time to this process."
In addition, the White House chief economic adviser Kudlow introduced at the press conference that day that the US economy is showing a V-shaped recovery in many areas. In the past four months, the retail industry has risen 121%, the manufacturing industry has risen 61%, and the automobile manufacturing has risen 6 times.
Larry Kudlow, Chief Economic Advisor to the White House: "There is a V-shaped recovery in the auto industry, which is a key area of the economy. We also have data on the housing industry, which is also confirmed as a V-shaped recovery."
Kudlow also introduced that after President Trump was elected, the median household income in the United States has risen by $6,000, which proves that Trump's economic policy only benefits the rich is wrong.
Chief Economic Advisor to the White House Kudlow said, "Living standards have improved, poverty has fallen, and inequality has shrunk. Therefore, President Trump's statement that only the rich benefited is untrue."
Kudlow said that there is more work to be done to restore employment, but the overall recovery trend of the US economy is sustainable.
According to data released by the US Department of Labor on 24 September, the number of first-time jobless claims in the US increased slightly last week, reaching 870,000. The number of consecutive claims for unemployment benefits fell by 167,000 to 12.6 million.
No comments:
Post a Comment